Published in J Infect Dis on March 15, 2005
The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol (2006) 3.62
Meningococcal carriage and disease--population biology and evolution. Vaccine (2009) 2.62
Whole-genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis. Proc Natl Acad Sci U S A (2008) 2.06
The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement. PLoS Pathog (2010) 1.81
The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens. Vaccine (2012) 1.71
Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev (2010) 1.70
Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines. Infect Immun (2008) 1.66
Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight- year longitudinal study in northern Ghana. PLoS Med (2007) 1.56
Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect Dis (2013) 1.47
Characterization of Carriage Isolates of Neisseria meningitides in the Adolescents and Young Adults Population of Bogota (Colombia). PLoS One (2015) 1.45
Population genomics: diversity and virulence in the Neisseria. Curr Opin Microbiol (2008) 1.34
Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada. J Clin Microbiol (2007) 1.30
Immunity to Neisseria meningitidis group B in adults despite lack of serum bactericidal antibody. Clin Vaccine Immunol (2007) 1.26
Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation. J Infect Dis (2011) 1.19
IS1301 fingerprint analysis of Neisseria meningitidis strains belonging to the ET-15 clone. J Clin Microbiol (2006) 1.16
A functional two-partner secretion system contributes to adhesion of Neisseria meningitidis to epithelial cells. J Bacteriol (2007) 1.16
Virulence evolution of the human pathogen Neisseria meningitidis by recombination in the core and accessory genome. PLoS One (2011) 1.12
Cytosolic proteins contribute to surface plasminogen recruitment of Neisseria meningitidis. J Bacteriol (2007) 1.10
Comparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulence. J Bacteriol (2010) 1.08
Genome flexibility in Neisseria meningitidis. Vaccine (2009) 1.06
Extensive genomic variation within clonal complexes of Neisseria meningitidis. Genome Biol Evol (2011) 1.06
Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease. Microbiol Mol Biol Rev (2013) 1.05
Persistence of hyperinvasive meningococcal strain types during global spread as recorded in the PubMLST database. PLoS One (2012) 1.04
An epidemiological review of changes in meningococcal biology during the last 100 years. Pathog Glob Health (2013) 1.02
Microbiological evaluation of the new VITEK 2 Neisseria-Haemophilus identification card. J Clin Microbiol (2007) 1.00
The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis? Philos Trans R Soc Lond B Biol Sci (2013) 0.99
Endotoxin, capsule, and bacterial attachment contribute to Neisseria meningitidis resistance to the human antimicrobial peptide LL-37. J Bacteriol (2009) 0.97
Domain exchange at the 3' end of the gene encoding the fratricide meningococcal two-partner secretion protein A. BMC Genomics (2013) 0.96
Differential modulation of TNF-alpha-induced apoptosis by Neisseria meningitidis. PLoS Pathog (2009) 0.96
Laboratory-based surveillance of Neisseria meningitidis isolates from disease cases in Latin American and Caribbean countries, SIREVA II 2006-2010. PLoS One (2012) 0.94
Deletion of the meningococcal fetA gene used for antigen sequence typing of invasive and commensal isolates from Germany: frequencies and mechanisms. J Clin Microbiol (2007) 0.93
Molecular discrimination between Neisseria meningitidis serogroups W-135 and Y based on the nucleotide recognition domain sequence of the capsule polymerases. J Clin Microbiol (2010) 0.92
Carriage rates and serogroups of Neisseria meningitidis among freshmen in a University dormitory in Korea. Yonsei Med J (2012) 0.91
Evolutionary and genomic insights into meningococcal biology. Future Microbiol (2012) 0.90
Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development. Clin Vaccine Immunol (2014) 0.88
Vaccine development against Neisseria meningitidis. Microb Biotechnol (2011) 0.87
MyD88-dependent signaling affects the development of meningococcal sepsis by nonlipooligosaccharide ligands. Infect Immun (2006) 0.85
Biofilm formation by the human pathogen Neisseria meningitidis. Med Microbiol Immunol (2010) 0.85
Virulence determinants involved in differential host niche adaptation of Neisseria meningitidis and Neisseria gonorrhoeae. Med Microbiol Immunol (2010) 0.84
Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines. Arch Dis Child (2007) 0.84
NafA negatively controls Neisseria meningitidis piliation. PLoS One (2011) 0.84
Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections. J Clin Microbiol (2015) 0.84
Genotypic and phenotypic characterization of carriage and invasive disease isolates of Neisseria meningitidis in Finland. J Clin Microbiol (2011) 0.84
Differential activation of acid sphingomyelinase and ceramide release determines invasiveness of Neisseria meningitidis into brain endothelial cells. PLoS Pathog (2014) 0.83
Transmigration of polymorphnuclear neutrophils and monocytes through the human blood-cerebrospinal fluid barrier after bacterial infection in vitro. J Neuroinflammation (2013) 0.82
The transcriptional repressor FarR is not involved in meningococcal fatty acid resistance mediated by the FarAB efflux pump and dependent on lipopolysaccharide structure. Appl Environ Microbiol (2010) 0.82
Opc expression, LPS immunotype switch and pilin conversion contribute to serum resistance of unencapsulated meningococci. PLoS One (2012) 0.82
ZnuD, a potential candidate for a simple and universal Neisseria meningitidis vaccine. Infect Immun (2013) 0.81
Can we, should we, eradicate the meningococcus? Vaccine (2012) 0.81
Influence of two vaccination campaigns on genetic diversity of invasive Neisseria meningitidis isolates in northern Spain (1997-2008). PLoS One (2009) 0.81
Inhibition of the classical pathway of complement by meningococcal capsular polysaccharides. J Immunol (2014) 0.80
Using single-nucleotide polymorphisms to discriminate disease-associated from carried genomes of Neisseria meningitidis. J Bacteriol (2011) 0.80
Neisseria meningitidis sequence type and risk for death, Iceland. Emerg Infect Dis (2006) 0.80
Meningococcal factor H binding protein fHbpd184 polymorphism influences clinical course of meningococcal meningitis. PLoS One (2012) 0.78
Prevalence and clinical course in invasive infections with meningococcal endotoxin variants. PLoS One (2012) 0.77
Mannose-Binding Lectin Gene, MBL2, Polymorphisms Do Not Increase Susceptibility to Invasive Meningococcal Disease in a Population of Danish Children. Open Forum Infect Dis (2015) 0.77
Neisseria meningitidis elicits a pro-inflammatory response involving IκBζ in a human blood-cerebrospinal fluid barrier model. J Neuroinflammation (2014) 0.76
Persistence of antibodies in laboratory staff immunized with quadrivalent meningococcal polysaccharide vaccine. J Occup Med Toxicol (2013) 0.76
Genome sequence of a Neisseria meningitidis capsule null locus strain from the clonal complex of sequence type 198. J Bacteriol (2012) 0.76
Genetic diversity and levels of expression of factor H binding protein among carriage isolates of Neisseria meningitidis. PLoS One (2014) 0.76
Increased Pilus Production Conferred by a Naturally Occurring Mutation Alters Host-Pathogen Interaction in Favor of Carriage in Streptococcus pyogenes. Infect Immun (2017) 0.75
Interstrain Cooperation in Meningococcal Biofilms: Role of Autotransporters NalP and AutA. Front Microbiol (2017) 0.75
Disease and Carrier Isolates of Neisseria meningitidis Cause G1 Cell Cycle Arrest in Human Epithelial Cells. Infect Immun (2016) 0.75
Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa. BMC Microbiol (2017) 0.75
Characterization of Oropharyngeal Carriage Isolates of Neisseria meningitidis in Healthy Korean Adolescents in 2015. J Korean Med Sci (2017) 0.75
Impact of Moderate Temperature Changes on Neisseria meningitidis Adhesion Phenotypes and Proteome. Infect Immun (2016) 0.75
Transcriptomic buffering of cryptic genetic variation contributes to meningococcal virulence. BMC Genomics (2017) 0.75
Molecular characterization of Neisseria meningitidis isolates recovered from 11-19-year-old meningococcal carriers in Salvador, Brazil. PLoS One (2017) 0.75
Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol (2003) 14.80
Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol (2006) 14.53
Report of the ad hoc committee for the re-evaluation of the species definition in bacteriology. Int J Syst Evol Microbiol (2002) 11.02
BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics (2010) 9.30
Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis (2012) 7.18
mlstdbNet - distributed multi-locus sequence typing (MLST) databases. BMC Bioinformatics (2004) 6.75
Multi-locus sequence typing: a tool for global epidemiology. Trends Microbiol (2003) 6.23
Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax. Proc Natl Acad Sci U S A (2004) 4.73
Multilocus sequence typing of Clostridium difficile. J Clin Microbiol (2009) 4.16
Molecular characterization of Campylobacter jejuni clones: a basis for epidemiologic investigation. Emerg Infect Dis (2002) 3.98
Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J Infect Dis (2008) 3.98
Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol (2005) 3.93
A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance. BMJ Open (2012) 3.93
The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol (2006) 3.62
Multilocus sequence typing system for the endosymbiont Wolbachia pipientis. Appl Environ Microbiol (2006) 3.45
Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease. Proc Natl Acad Sci U S A (2012) 3.29
The "case-chaos study" as an adjunct or alternative to conventional case-control study methodology. Am J Epidemiol (2012) 3.11
Population structure and evolution of the Bacillus cereus group. J Bacteriol (2004) 3.08
PorA variable regions of Neisseria meningitidis. Emerg Infect Dis (2004) 3.08
Whole-genome sequencing shows that patient-to-patient transmission rarely accounts for acquisition of Staphylococcus aureus in an intensive care unit. Clin Infect Dis (2013) 3.05
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis (2013) 2.95
Sequence typing and comparison of population biology of Campylobacter coli and Campylobacter jejuni. J Clin Microbiol (2005) 2.88
Ribosomal multilocus sequence typing: universal characterization of bacteria from domain to strain. Microbiology (2012) 2.72
Campylobacter genotyping to determine the source of human infection. Clin Infect Dis (2009) 2.70
Cardiovascular safety of tiotropium in patients with COPD. Chest (2009) 2.70
MLST revisited: the gene-by-gene approach to bacterial genomics. Nat Rev Microbiol (2013) 2.64
Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component. Microbiology (2003) 2.62
Meningococcal carriage and disease--population biology and evolution. Vaccine (2009) 2.62
The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus. Proc Natl Acad Sci U S A (2003) 2.62
Antigenic shift and increased incidence of meningococcal disease. J Infect Dis (2006) 2.49
Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design. Infect Immun (2004) 2.44
Convergence of Campylobacter species: implications for bacterial evolution. Science (2008) 2.42
Molecular phylogenetics of Candida albicans. Eukaryot Cell (2007) 2.41
Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol (2004) 2.41
Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease. Mayo Clin Proc (2008) 2.37
RIDOM: Ribosomal Differentiation of Medical Micro-organisms Database. Nucleic Acids Res (2002) 2.33
RIDOM: comprehensive and public sequence database for identification of Mycobacterium species. BMC Infect Dis (2003) 2.33
Host-associated genetic import in Campylobacter jejuni. Emerg Infect Dis (2007) 2.28
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin J Am Soc Nephrol (2007) 2.26
Public perception of climate change voluntary mitigation and barriers to behavior change. Am J Prev Med (2008) 2.25
Optimization and validation of multilocus sequence typing for Candida albicans. J Clin Microbiol (2003) 2.18
Many carried meningococci lack the genes required for capsule synthesis and transport. Microbiology (2002) 2.17
Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol (2005) 2.17
Mismatch induced speciation in Salmonella: model and data. Philos Trans R Soc Lond B Biol Sci (2006) 2.11
Whole-genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis. Proc Natl Acad Sci U S A (2008) 2.06
Molecular typing of meningococci: recommendations for target choice and nomenclature. FEMS Microbiol Rev (2006) 2.05
Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS One (2011) 2.04
Microevolutionary analysis of Clostridium difficile genomes to investigate transmission. Genome Biol (2012) 2.04
Population structure and properties of Candida albicans, as determined by multilocus sequence typing. J Clin Microbiol (2005) 2.04
Structural and functional investigation of the intermolecular interaction between NRPS adenylation and carrier protein domains. Chem Biol (2012) 1.99
Impact of recombination on bacterial evolution. Trends Microbiol (2010) 1.98
Public perception and behavior change in relationship to hot weather and air pollution. Environ Res (2008) 1.92
A chromosomally integrated bacteriophage in invasive meningococci. J Exp Med (2005) 1.88
Genomic evidence for the evolution of Streptococcus equi: host restriction, increased virulence, and genetic exchange with human pathogens. PLoS Pathog (2009) 1.87
Campylobacter genotypes from food animals, environmental sources and clinical disease in Scotland 2005/6. Int J Food Microbiol (2009) 1.83
Molecular analysis of bacteria in periodontitis: evaluation of clone libraries, novel phylotypes and putative pathogens. Microbiology (2003) 1.83
The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement. PLoS Pathog (2010) 1.81
A genomic approach to bacterial taxonomy: an examination and proposed reclassification of species within the genus Neisseria. Microbiology (2012) 1.79
Spatiotemporal analysis of invasive meningococcal disease, Germany. Emerg Infect Dis (2006) 1.78
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study. J Am Coll Cardiol (2008) 1.73
Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD. Am J Kidney Dis (2009) 1.68
Within-host evolution of Staphylococcus aureus during asymptomatic carriage. PLoS One (2013) 1.67
Multilocus sequence typing for differentiation of strains of Candida tropicalis. J Clin Microbiol (2005) 1.66
Population structure of the Yersinia pseudotuberculosis complex according to multilocus sequence typing. Environ Microbiol (2011) 1.64
Molecular evidence for dissemination of unique Campylobacter jejuni clones in Curaçao, Netherlands Antilles. J Clin Microbiol (2003) 1.64
Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidis. Proc Natl Acad Sci U S A (2008) 1.63
Genetic basis for nongroupable Neisseria meningitidis. J Infect Dis (2003) 1.62
A surveillance network for meningococcal disease in Europe. FEMS Microbiol Rev (2006) 1.62
Phylogenetic evidence for frequent positive selection and recombination in the meningococcal surface antigen PorB. Mol Biol Evol (2002) 1.60
Evolution of bacteriophages infecting encapsulated bacteria: lessons from Escherichia coli K1-specific phages. Mol Microbiol (2006) 1.60
Cowpox virus infection in pet rat owners: not always immediately recognized. Dtsch Arztebl Int (2009) 1.58
Assigning the source of human campylobacteriosis in New Zealand: a comparative genetic and epidemiological approach. Infect Genet Evol (2009) 1.58
Multilocus sequence typing for global surveillance of meningococcal disease. FEMS Microbiol Rev (2006) 1.56
Interlaboratory comparison of PCR-based identification and genogrouping of Neisseria meningitidis. J Clin Microbiol (2005) 1.56
Neisserial lipooligosaccharide is a target for complement component C4b. Inner core phosphoethanolamine residues define C4b linkage specificity. J Biol Chem (2003) 1.55
Getting a grip on strangles: recent progress towards improved diagnostics and vaccines. Vet J (2006) 1.55